Načítá se...

TCMIP v2.0 Powers the Identification of Chemical Constituents Available in Xinglou Chengqi Decoction and the Exploration of Pharmacological Mechanisms Acting on Stroke Complicated With Tanre Fushi Syndrome

Xinglou Chengqi (XLCQ) decoction, composed of three botanical drugs and one inorganic drug, is used in clinics during the treatment of acute stroke complicated with Tanre Fushi (TRFS) syndrome in China. However, its active ingredients and the molecular mechanism have not been clarified. So, we aimed...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Pharmacol
Hlavní autoři: Wang, Ping, Wang, Shuang, Chen, Hong, Deng, Xiaofang, Zhang, Luoqi, Xu, Haiyu, Yang, Hongjun
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2021
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8320350/
https://ncbi.nlm.nih.gov/pubmed/34335236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.598200
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!